CTTNBP2 inhibitors belong to a distinct chemical class designed to target a specific protein known as Cortactin-binding protein 2 (CTTNBP2). This class of compounds is developed primarily for research and experimental purposes, aiming to elucidate the role and function of CTTNBP2 within biological systems. CTTNBP2 is a critical protein involved in cellular processes related to cell migration, cytoskeletal organization, and cell adhesion. By inhibiting CTTNBP2, researchers can gain valuable insights into the underlying molecular mechanisms that govern these fundamental cellular activities.
The inhibitors within this chemical class are typically small molecules or biologically active compounds designed to bind specifically to CTTNBP2 and interfere with its normal functioning. They are meticulously designed to disrupt protein-protein interactions or block essential binding sites, thereby inhibiting the downstream signaling pathways associated with CTTNBP2. These inhibitors are instrumental tools in cell biology and molecular biology research, enabling scientists to dissect the intricate web of molecular interactions that contribute to processes like cell migration, adhesion, and cytoskeletal dynamics. Additionally, by studying the effects of CTTNBP2 inhibition, researchers can potentially uncover novel targets and develop a deeper understanding of the role of this protein in various cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor that may alter CTTNBP2 activity by modifying cortactin phosphorylation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor that can influence the cytoskeletal regulation in which CTTNBP2 is involved. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Inhibits Src family kinases and could modify CTTNBP2-associated signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor potentially affecting processes regulated by CTTNBP2 through JNK-mediated pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can impact actin cytoskeleton dynamics, potentially affecting CTTNBP2 function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that may indirectly alter CTTNBP2's role in actin cytoskeleton regulation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that could impact pathways involving CTTNBP2 and cortactin. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, which can affect the actin cytoskeleton and potentially influence CTTNBP2 function. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
PKC inhibitor that may affect cellular processes involving CTTNBP2 by altering PKC activity. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Cdc42 inhibitor that could alter the actin dynamics, potentially impacting CTTNBP2's interactions. | ||||||